Home
Abivax

Abivax Market Share Analysis for August 2026

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Health > Biotechnology and Pharmaceuticals

Domainabivax.com

Year Founded2013

Employees51 - 200

Annual Revenue< $1M

Abivax

Abivax (including company regionals)

abivax.com

See more website traffic and engagement information

Total visits to Abivax's top domains

Understand Abivax market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

abivax.com22.9K

See more with Sales Intelligence

Avg. visit duration in Abivax's top domains

Analyze Abivax engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

abivax.com00:00:23

See more with Sales Intelligence

Avg. pageviews on Abivax's top domains

See how Abivax keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

abivax.com1.66

See more with Sales Intelligence

Abivax top competitors by domain

Top similar sites in August 2026, ranked by their affinity

ipsen.comCompany NameIpsenEmployees5001 - 10000HQFrance, Boulogne-BillancourtAnnual revenue> $1BTotal visits100KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Abivax

These are the website technologies, by industry, used by Abivax top domains

Payment & Currencies (11)

Cart Functionality

Conversion & Analytics (4)

Google Analytics

eCommerce (4)

OpenCart

Advertising (3)

LinkedIn Advertiser

More Technologies

11

See all

News & Signals from Abivax

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAbivax hired Ivan Nuñez-Pacheco as Global Head of Patient Services on Sep 9th '26.Abivax has appointed Ivan Nuñez-Pacheco as Global Head of Patient Services.

NewsAbivax hired Berger as Global Head of Marketing on Sep 7th '26.On the appointment of Berger, Michael Nesrallah, Chief Commercial Officer of Abivax, said: "We are strengthening our Commercial Leadership Team with an accomplished executive who bring deep expertise in inflammatory bowel disease."

NewsAbivax had revenue of $1.56M on Aug 1st '26.* Abivax shares opened at $124.92, while the company reported a quarterly loss of $0.71 per share - better than the expected $0.94 loss - and revenue of $1.56 million, above estimates.